Work

Efficacy and safety of ashwagandha root extract in children and adolescents with mild attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Abstract: < 0.001). No significant between-group differences or clinically meaningful changes were observed in safety markers across the intervention period. No serious adverse events were reported. Supplementation with 300 mg/day of ashwagandha root extract for 56 days significantly improved ADHD symptom severity, executive functioning, and selected patient-reported outcomes in children and adolescents with mild ADHD, with a favorable safety profile.

Source: Journal of Medicine and Life

DOI: 10.25122/jml-2026-0025

Authors: Mukta Jain, Sunil Naik, Gudla Muralidhar, Bade Srinivas Rao, Sanjay Agarwal

Institutions: MGM Medical College, Nerul, Government of Andhra Pradesh, DY Patil Deemed to be University

Language: English

Topic: Phytochemicals and Medicinal Plants

Subfield: Complementary and alternative medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W7203560047

FWCI:

Cites:

Cited by:

Related to: 10